Latest News

July 18, 2022: The ABC reports that over the last two years, the  Federal government purchased 255 million vaccines from four pharmaceutical companies, with 60 million administered around the country, and roughly 40 million doses donated around the Indo-Pacific region. Even with the expected increased uptake of third and fourth doses over winter, Australia may have a surplus of over 100 million doses, some of which are due to expire.

July 11, 2022: A key parliamentary committee in the UK has urged the British government to extend the period of scrutiny on the Australia-UK Free Trade Agreement (A-UKFTA), after ministers were accused of pushing it through parliament without proper inspection.

7 July 2022: Trade justice activists in Sydney came together this week at a Politics in the Pub event to discuss the prospects of progressing a trade justice agenda under the new Labor government.

30 June, 2022: Speaking to RN Drive on ABC Radio National, Dr Patricia Ranald, AFTINET Convenor, has warned that a potential trade deal containing EU standards in past trade deals, though welcome, may fall short of community expectations for high environmental and labour standards without strong enforcement mechanisms

June 30, 2022: Earlier this month, trade ministers from 164 member states of the World Trade Organisation (WTO) came together at the WTO’s 12^th Ministerial Conference (MC12) to negotiate new rules to govern a number of important areas of trade. 

What were the results of the MC12, and what impact will it have on people, the planet, and sustainable development? Here’s what you need to know.

June 27, 2022: After two years of negotiations, members of the Energy Charter Treaty (ECT) have arrived at an ‘Agreement in Principle’ which fails to end special protections for fossil fuel investments through Investor-State Dispute Settlement mechanisms (ISDS).

June 22, 2022: Following the weak WTO decision on COVID9 vaccine patents only, AFTINET has warned that the agreement will fail to address global inequities in access to vaccines, tests, and treatments.

Media Release                                                                                                      June 17, 2022

After nearly two years of delay, the World Trade Organisation (WTO) Ministerial Conference has produced a weak decision on COVID-19 medicine monopolies which covers only vaccines, excludes non-patent intellectual property barriers, and contains restrictions which are more onerous than some existing WTO rules. This condemns the world’s most vulnerable people to inequitable access to vaccines and treatments. They will continue to die in greater numbers than those lucky enough to live in high income countries.

June 16, 2022: As the World Trade Organisation (WTO) meets this week to decide on lifting patent monopolies over COVID19 medicines, public health experts have written an analysis in Croakey Health Media examining how Australia support a meaningful outcome at the WTO.

June 16, 2022: AFTINET has joined with more than 220 civil society organisations across the globe to demand the World Trade Organisation (WTO) reject the current negotiating text, which vaccine equity advocates say could set a negative precedent for access to medicines during future pandemics.